Form4insider filings, from the source

SEC Form 4 · accession 0001055726-17-000010

INOVIO PHARMACEUTICALS, INC. · INO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Niranjan Sardesai
Officer — Chief Operating Officer
Period of report
Mar 9, 2017
Accepted (ET)
Mar 13, 2017 · 5:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 9, 2017M25,000—A88,513D
Common StockMar 9, 2017F7,648$6.61D80,865D
Common StockF2Mar 10, 2017M6,077—A86,942D
Common StockMar 10, 2017F1,859$6.68D85,083D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitF1—Mar 9, 2017M25,000D——Common Stock25,00050,000D
Common Stock OptionF3$6.68Mar 10, 2017A100,000AMar 10, 2017Mar 10, 2027Common Stock100,000100,000D
Restricted Stock UnitF4—Mar 10, 2017A61,300A——Common Stock61,30061,300D

Explanation of responses